Single-Injection Showdown: Orthopedic Giant vs. Pharma Leader
Both Gel-One and Synvisc-One deliver complete HA treatment in a single injection. They are both avian-derived and both cross-linked. But they come from very different companies with different formulations, and understanding those differences can help you make a more informed decision with your doctor.
If you are comparing single-injection knee gel shots, these are two of the four options available in the US (the others being Monovisc and Durolane). Here is how Gel-One and Synvisc-One stack up.
Quick Comparison Table
| Feature | Gel-One | Synvisc-One |
|---|---|---|
| Manufacturer | Zimmer Biomet | Sanofi |
| Injections needed | 1 | 1 |
| Volume | 3 mL | 6 mL |
| Molecular weight | High (500-730 kDa) | Very high (6 million Da) |
| Cross-linked | Yes | Yes (hylan G-F 20) |
| Source | Avian (rooster comb) | Avian (rooster comb) |
| Bird allergy safe | No | No |
| FDA approval | 2011 | 2009 |
| HCPCS Code | J7326 | J7325 |
| Duration of relief | 4-6 months | Up to 6 months |
| Self-pay cost | $700-$1,000 | $800-$1,200 |
| Medicare covered | Yes | Yes |
Gel-One: From the Joint Replacement Experts
What It Is
Gel-One comes from Zimmer Biomet, a global leader in orthopedic implants and joint replacement. They know joints—and they’ve created a single-injection HA with a smaller volume footprint.
Key Advantages
Considerations
Synvisc-One: The Original Single-Shot
What It Is
Synvisc-One from Sanofi was the first single-injection HA to hit the market. It contains hylan G-F 20—a very high molecular weight, cross-linked hyaluronic acid.
Key Advantages
Considerations
The Volume Question
| Aspect | Gel-One (3 mL) | Synvisc-One (6 mL) |
|---|---|---|
| Post-injection swelling | Less likely | More common |
| Immediate discomfort | Less | More |
| Total HA delivered | Less | More |
| Theoretical cushioning | Lower | Higher |
Clinical reality: Despite the volume difference, patient outcomes are similar. The extra volume in Synvisc-One doesn’t necessarily translate to better or longer relief.
Allergy Warning
Both Require Allergy Screening
Neither Gel-One nor Synvisc-One is safe for:
- Egg allergies
- Chicken allergies
- Feather allergies
- Any poultry sensitivity
If you have avian allergies, consider Durolane (single-injection, non-avian) instead.
Cost Comparison
| Factor | Gel-One | Synvisc-One |
|---|---|---|
| Self-pay | $700-$1,000 | $800-$1,200 |
| Medicare typical | $100-$300 | $100-$350 |
| Relative position | Often lower | Often higher |
Making Your Decision
Choose Gel-One if:
- You prefer smaller injection volume
- Cost is a significant factor
- You’ve used Zimmer Biomet products before
- Your provider recommends it
Choose Synvisc-One if:
- You want the highest molecular weight option
- You prefer the most established product
- Your provider has extensive Synvisc experience
- Insurance covers both equally
The Bottom Line
Both Deliver Single-Injection Convenience
Gel-One and Synvisc-One are both effective single-injection treatments. The differences:
- Gel-One: Smaller volume, lower cost, from the joint replacement experts
- Synvisc-One: Higher molecular weight, more data, the original single-shot
For most patients, either works well. Choose based on cost, volume preference, and provider recommendation.
Find Single-Injection Specialists
Connect with providers experienced in both Gel-One and Synvisc-One.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderThe Molecular Weight Debate
The biggest formulation difference between these products is molecular weight:
- Gel-One: 500-730 kDa (cross-linked)
- Synvisc-One: 6 million Da (cross-linked hylan polymer)
That is roughly a 10x difference. Does it matter clinically?
Research comparing different molecular weight HA products has not found consistent superiority for higher MW. While higher MW creates a more viscous gel that theoretically provides better cushioning, clinical trials show similar pain relief outcomes across the MW spectrum. Individual patient biology plays a larger role than molecular weight in determining response.
Clinical Evidence
Gel-One Studies
- FDA-approved based on multicenter RCT showing superiority over saline placebo
- Real-world data confirm effectiveness for mild-to-moderate knee OA
- Safety profile comparable to other cross-linked HA products
Synvisc-One Studies
- 15+ years of post-market safety surveillance
- Largest body of single-injection HA evidence
- Multiple real-world effectiveness studies corroborate clinical trial results
- Repeat treatment series show sustained benefit
Frequently Asked Questions
Is Gel-One or Synvisc-One more effective for knee arthritis?
Clinical studies show similar pain relief for both products. Neither has been proven superior in head-to-head comparisons. The higher molecular weight of Synvisc-One has not translated to measurably better outcomes in available research.
Does Medicare cover both Gel-One and Synvisc-One?
Yes. Both are covered by Medicare Part B when medically necessary for knee osteoarthritis. Typical patient copay is $100-$350 per treatment, depending on your supplemental coverage.
Can I switch from Synvisc-One to Gel-One or vice versa?
Yes. Switching between HA products is safe and common. Some patients respond better to one formulation, so trying a different brand after inadequate relief is a reasonable approach.
Which has fewer side effects?
Both have similar side effect profiles. Temporary pain, swelling, or redness at the injection site is the most common issue. Synvisc-One’s larger volume (6 mL) may cause slightly more temporary swelling, but this typically resolves within 24-48 hours.
Does the injection volume (3 mL vs 6 mL) affect results?
The volume difference has not been shown to affect pain relief outcomes. Some patients prefer the smaller 3 mL volume of Gel-One because it may cause less temporary post-injection swelling and discomfort.
Are both safe if I need knee replacement later?
Yes. Neither product interferes with future surgical options. HA injections are fully biodegradable and do not affect joint replacement surgery.
References
- Gel-One (cross-linked sodium hyaluronate) Prescribing Information. Zimmer Biomet.
- Synvisc-One (hylan G-F 20) Prescribing Information. Sanofi.
- Comparative effectiveness of single-injection viscosupplements for knee OA. Cartilage. 2020.
- CMS LCD L39529 - Viscosupplementation for Knee OA. Medicare Coverage Database
Related Comparisons
- Gel-One vs. Durolane
- Monovisc vs. Synvisc-One
- Gel-One vs. Orthovisc
- Single Injection vs. Series
- Medicare Coverage for Knee Injections
HA Injection Updates
Get the latest comparisons and guidance for knee osteoarthritis treatments.
Join 10,000+ readers. No spam.